ReviewFrontiers in immunology2026

Innate immune signaling-driven myeloid remodeling in cancer: inflammatory amplification, immune suppression, and therapeutic targeting.

Wenyi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.